Skip to main content
    A

    Axsome Therapeutics Inc (AXSM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $135.95
    -1.06 (-0.77%)

    Market Cap: $7.45B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Axsome Therapeutics Inc (AXSM) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Axsome Therapeutics (AXSM) has a latest price of $135.95 on Nov 17, 2026, 47.7% below its 52-week high of $260.19. Its price fell 2.7% over the past 12 months. The month-end price rose 2,055.7% over the 10 years through Oct 2026, a compound annual rate of 35.9%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $244.77 in Jun 2026 and its lowest $2.45 in Mar 2018, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart AXSM with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for AXSM.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 37.7%, and over 6 months it fell 40.0%. The month-end price rose 131.9% over the 3 years through Oct 2026, a compound annual rate of 32.4%.

    PeriodChange
    1 month-12.7%
    3 months-37.7%
    6 months-40.0%
    12 months-2.7%
    12 months, with dividends-2.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+131.9%+32.4%
    5 years+275.1%+30.3%
    10 years+2,055.7%+35.9%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 3,565.2%, and its weakest was 2021, when it fell 53.6%.

    YearCloseChange
    2026 through Oct 2026$144.43-20.9%
    2025$182.64+115.9%
    2024$84.61+6.3%
    2023$79.59+3.2%
    2022$77.13+104.2%
    2021$37.78-53.6%
    2020$81.47-21.2%
    2019$103.36+3,565.2%
    2018$2.82-49.6%
    2017$5.60-17.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 19.4% below its 50-day average of $168.62 and 30.8% below its 200-day average of $196.56.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$135.95
    52-week high$260.19-47.7%
    52-week low$123.00+10.5%
    50-day average$168.62-19.4%
    200-day average$196.56-30.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 49.1%.

    MeasureValue
    1-year beta0.72
    Largest fall, 1 year-49.1%
    Largest fall, 3 years-49.1%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About AXSM

    What is AXSM's 1-year price change?

    Axsome Therapeutics's price fell 2.7% over the past 12 months. With dividends included, the 12-month total return was -2.7%.

    What is AXSM's 5-year price change?

    Axsome Therapeutics's month-end price rose 275.1% over the 5 years through Oct 2026, a compound annual rate of 30.3%. These figures leave out dividends.

    What is AXSM's 52-week high and low?

    Axsome Therapeutics's 52-week high is $260.19 and its 52-week low is $123.00. Its latest price of $135.95 on Nov 17, 2026 is 47.7% below the high.

    What is AXSM's beta?

    Axsome Therapeutics's 1-year beta against the S&P 500 is 0.72, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 49.1%.

    Is the AXSM chart free?

    Yes. Advanced Charting for AXSM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.